# LYMPHIR
> **BLA761312** · Biologics License Application · Sponsor: CITIUS PHARMS · Approved 2024-08-07
## Drug
- **FDA Application Number:** BLA761312
- **Application type:** Biologics License Application
- **Brand name:** LYMPHIR
- **Generic name:** DENILEUKIN DIFTITOX-CXDL
- **Active ingredients:** DENILEUKIN DIFTITOX-CXDL
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** CITIUS PHARMS
- **Manufacturer:** Citius Pharmaceuticals, Inc.
- **First approval:** 2024-08-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761312)
---
*MORVS · CC0 1.0*